Impact of obesity on ovotoxicity induced by 7,12-dimethylbenz[a]anthracene in mice

Biology of Reproduction

Volumn 90, Issue 3, 2014, Pages

  Nteeba, Jackson ^a   Ganesan, Shanthi ^a   Keating, Aileen F ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

7,12 dimethylbenz a anthracene; Environmental contaminants and toxicants; Obesity; Ovary; Ovotoxicity

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; COMPLEMENTARY DNA; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA; PROTEIN KINASE B; PROTEIN KINASE B BETA; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; OBESITY; OOCYTE; OVARY; OVARY FOLLICLE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

7,12-DIMETHYLBENZ[A]ANTHRACENE; ENVIRONMENTAL CONTAMINANTS AND TOXICANTS; OBESITY; OVARY; OVOTOXICITY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; DNA, COMPLEMENTARY; EPOXIDE HYDROLASES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GLUTATHIONE TRANSFERASE; INDICATORS AND REAGENTS; INSULIN; MICE; OBESITY; ONCOGENE PROTEIN V-AKT; ORGAN SIZE; OVARIAN FOLLICLE; OVARY; OVUM; PHOSPHATIDYLINOSITOL 3-KINASES; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER;

EID: 84897481540     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.114215     Document Type: Article

References (115)

1. Fatani S, Itua I, Clark P, Wong C, Naderali EK. The effects of dietinduced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage. Int J Gen Med 2011; 4:211-219.
2. Akamine EH, Marcal AC, Camporez JP, Hoshida MS, Caperuto LC, Bevilacqua E, Carvalho CR. Obesity induced by high-fat diet promotes insulin resistance in the ovary. J Endocrinol 2010; 206:65-74.
3. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009; 28:w822-w831.
4. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 2011; 11:564.
5. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17:961-969.
6. Wild SH, Byrne CD. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ 2006; 333:1009-1011.
7. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
8. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53:1925-1932.
9. Artham SM, Lavie CJ, Milani RV, Ventura HO. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J 2009; 9: 124-132.
10. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002; 11:822-828.
11. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4:579-591.
12. Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S. Obesity and women's health: an evidence-based review. J Am Board Family Med 2011; 24:75-85.
13. Lane G. Obesity and gynaecological cancer. Menopause Int 2008; 14: 33-37.
14. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Collaboration MWS. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335:1134.
15. Prentice A, Webb F. Obesity amidst poverty. Int J Epidemiol 2006; 35: 24-30.
16. Baalwa J, Byarugaba BB, Kabagambe EK, Kabagambe KE, Otim AM. Prevalence of overweight and obesity in young adults in Uganda. Afr Health Sci 2010; 10:367-373.
17. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006; 65:137-145.
18. Barber TM, Franks S. The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today? Womens Health (Lond Engl) 2012; 8:147-154.
19. Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction 2010; 140:347-364.
20. Dravecka I, Lazurova I, Kraus V. Obesity is the major factor determining an insulin sensitivity and androgen production in women with anovulary cycles. Bratisl Lek Listy 2003; 104:393-399.
21. Rachoń D, Teede H. Ovarian function and obesity-interrelationship, impact on women's reproductive lifespan and treatment options. Mol Cell Endocrinol 2010; 316:172-179.
22. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379:2162-2172.
23. Gilboa SM, Correa A, Botto LD, Rasmussen SA, Waller DK, Hobbs CA, Cleves MA, Riehle-Colarusso TJ. Study NBDP. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 2010; 202(51):e51-51.e10.
24. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009; 301:636-650.
25. Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol 2010; 88:804-810.
26. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 2008; 198:611-619.
27. Rasmussen KM, Kjolhede CL. Maternal obesity: a problem for both mother and child. Obesity (Silver Spring) 2008; 16:929-931.
28. Ma C, Carmichael SL, Scheuerle AE, Canfield MA, Shaw GM. Study NBDP. Association of microtia with maternal obesity and periconceptional folic acid use. Am J Med Genet A 2010; 152A:2756-2761.
29. Bellver J, Melo MA, Bosch E, Serra V, Remohí J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril 2007; 88:446-451.
30. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology-a systematic review. Hum Reprod Update 2007; 13:433-444.
31. Hoyer PB. Can the clock be turned back on ovarian aging? Sci Aging Knowl Environ 2004; 2004:pe11.
32. Bhattacharya P, Keating AF. Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity. Toxicol Appl Pharmacol 2012; 261:227-235.
33. Anderson LD, Hirshfield AN. An overview of follicular development in the ovary: from embryo to the fertilized ovum in vitro. Md Med J 1992; 41:614-620.
34. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev 2009; 30:624-712.
35. Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol 1991; 124:43-101.
36. Elvin JA, Matzuk MM. Mouse models of ovarian failure. Rev Reprod 1998; 3:183-195.
37. Adhikari D, Liu K. Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocr Rev 2009; 30:438-464.
38. Reddy P, Zheng W, Liu K. Mechanisms maintaining the dormancy and survival of mammalian primordial follicles. Trends Endocrinol Metab 2010; 21:96-103.
39. Hsueh AJ, McGee EA, Hayashi M, Hsu SY. Hormonal regulation of early follicle development in the rat ovary. Mol Cell Endocrinol 2000; 163:95-100.
40. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000; 21:200-214.
41. Peters H, Byskov AG, Himelstein-Braw R, Faber M. Follicular growth: the basic event in the mouse and human ovary. J Reprod Fertil 1975; 45: 559-566.
42. Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, Shen Y, Du C, Tang W, Hämäläinen T, Peng SL, Lan ZJ, Cooney AJ, et al. Oocytespecific deletion of Pten causes premature activation of the primordial follicle pool. Science 2008; 319:611-613.
43. Wu S, Divall S, Wondisford F, Wolfe A. Reproductive tissues maintain insulin sensitivity in diet-induced obesity. Diabetes 2012; 61:114-123.
44. Kalra A, Nair S, Rai L. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci 2006; 60:447-453.
45. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 2007; 4:13-19.
46. Fatani S, Abubakari AR, Itua I, Wong C, Thomas C, Naderali EK. Effects of diet-induced obesity on protein expression in insulin signaling pathways of skeletal muscle in male Wistar rats. Int J Gen Med 2012; 5: 573-582.
47. Sweet LJ, Morrison BD, Pessin JE. Isolation of functional alpha beta heterodimers from the purified human placental alpha 2 beta 2 heterotetrameric insulin receptor complex. A structural basis for insulin binding heterogeneity. J Biol Chem 1987; 262:6939-6942.
48. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Müller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122-2125.
49. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20: 535-582.
50. Fayard E, Tintignac LA, Baudry A, Hemmings BA. Protein kinase B/Akt at a glance. J Cell Sci 2005; 118:5675-5678.
51. Bhattacharya P, Keating AF. Ovarian metabolism of xenobiotics. Exp Biol Med (Maywood) 2011; 236:765-771.
52. Borman SM, Christian PJ, Sipes IG, Hoyer PB. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol Applied Pharmacol 2000; 167:191-198.
53. Keating AF, Sen N, Sipes IG, Hoyer PB. Dual protective role for glutathione S-transferase class pi against VCD-induced ovotoxicity in the rat ovary. Toxicol Appl Pharmacol 2010; 247:71-75.
54. Hoyer PB, Davis JR, Bedrnicek JB, Marion SL, Christian PJ, Barton JK, Brewer MA. Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure. Gynecol Oncol 2009; 112:610-615.
55. Crist KA, Zhang Z, You M, Gunning WT, Conran PB, Steele VE, Lubet RA. Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 2005; 26:951-957.
56. Li N, Chen X, Han C, Chen J. Chemopreventive effect of tea and curcumin on DMBA-induced oral carcinogenesis in hamsters [in Chinese]. Wei Sheng Yan Jiu 2002; 31:354-357.
57. Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996; 39:7-20.
58. Kanter EM, Walker RM, Marion SL, Brewer M, Hoyer PB, Barton JK. Dual modality imaging of a novel rat model of ovarian carcinogenesis. J Biomed Opt 2006; 11:041123.
59. Igawa Y, Keating AF, Rajapaksa KS, Sipes IG, Hoyer PB. Evaluation of ovotoxicity induced by 7, 12-dimethylbenz[a]anthracene and its 3,4-diol metabolite utilizing a rat in vitro ovarian culture system. Toxicol Appl Pharmacol 2009; 234:361-369.
60. Keating AF, J Mark C, Sen N, Sipes IG, Hoyer PB. Effect of phosphatidylinositol-3 kinase inhibition on ovotoxicity caused by 4- vinylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries. Toxicol Appl Pharmacol 2009; 241:127-134.
61. Rajapaksa KS, Sipes IG, Hoyer PB. Involvement of microsomal epoxide hydrolase enzyme in ovotoxicity caused by 7,12-dimethylbenz[a]anthracene. Toxicol Sci 2007; 96:327-334.
62. Sowers MR, McConnell D, Yosef M, Jannausch ML, Harlow SD, Randolph JF. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci 2010; 1204:95-103.
63. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000; 35:3-9.
64. Jick H, Porter J. Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977; 1:1354-1355.
65. Mattison DR. Morphology of oocyte and follicle destruction by polycyclic aromatic hydrocarbons in mice. Toxicol Appl Pharmacol 1980; 53:249-259.
66. Weitzman GA, Miller MM, London SN, Mattison DR. Morphometric assessment of the murine ovarian toxicity of 7,12-dimethylbenz(a)anthracene. Reprod Toxicol 1992; 6:137-141.
67. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, Tilly JL. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001; 28:355-360.
68. Otto S, Bhattacharyya KK, Jefcoate CR. Polycyclic aromatic hydrocarbon metabolism in rat adrenal, ovary, and testis microsomes is catalyzed by the same novel cytochrome P450 (P450RAP). Endocrinology 1992; 131:3067-3076.
69. Miyata M, Kudo G, Lee YH, Yang TJ, Gelboin HV, Fernandez-Salguero P, Kimura S, Gonzalez FJ. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J Biol Chem 1999; 274:23963-23968.
70. Miyata M, Motoki K, Tamura E, Furukawa M, Gonzalez FJ, Yamazoe Y. Relative importance of maternal and embryonic microsomal epoxide hydrolase in 7,12-dimethylbenz[a]anthracene-induced developmental toxicity. Biochem Pharmacol 2002; 63:1077-1084.
71. Becedas L, Romert L, Toft E, Jenssen D, DePierre JW, Ahlberg MB. Metabolism of polycyclic aromatic hydrocarbons to mutagenic species by rat and porcine ovarian granulosa cells: detection by cocultivation with V79 Chinese hamster cells. Reprod Toxicol 1993; 7:219-224.
72. Bengtsson M, Hamberger L, Rydström J. Metabolism of 7,12- dimethylbenz(a)anthracene by different types of cells in the human ovary. Xenobiotica 1988; 18:1255-1270.
73. Kim SK, Novak RF. The role of intracellular signaling in insulinmediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther 2007; 113:88-120.
74. Thomas H, Schladt L, Knehr M, Oesch F. Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione Stransferases and peroxisomal beta-oxidation. Biochem Pharmacol 1989; 38:4291-4297.
75. Bhattacharya P, Sen N, Hoyer PB, Keating AF. Ovarian expressed microsomal epoxide hydrolase: role in detoxification of 4-vinylcyclohexene diepoxide and regulation by phosphatidylinositol-3 kinase signaling. Toxicol Appl Pharmacol 2012; 258:118-123.
76. Bhattacharya P, Keating AF. Protective role for ovarian glutathione Stransferase isoform pi during 7,12-dimethylbenz[a]anthracene-induced ovotoxicity. Toxicol Appl Pharmacol 2012; 260:201-208.
77. Bhattacharya P, Madden JA, Sen N, Hoyer PB, Keating AF. Glutathione S-transferase class mu regulation of apoptosis signal-related kinase 1 protein during VCD-induced ovotoxicity in neonatal rat ovaries. Toxicol Appl Pharmacol 2013; 267:49-56.
78. Board PG, Menon D. Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta 2013; 1830: 3267-3288.
79. Flaws JA, Doerr JK, Sipes IG, Hoyer PB. Destruction of preantralfollicles in adult rats by 4-vinyl-1-cyclohexene diepoxide. Reprod Toxicol 1994; 8:509-514.
80. Pedersen T, Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 1968; 17:555-557.
81. Nteeba J, Ross JW, Perfield JW II, Keating AF. High fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression. Reproductive Toxicology 2013; 42:68-77.
82. Kim SK, Woodcroft KJ, Novak RF. Insulin and glucagon regulation of glutathione S-transferase expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 2003; 305:353-361.
83. Kim SK, Woodcroft KJ, Kim SG, Novak RF. Insulin and glucagon signaling in regulation of microsomal epoxide hydrolase expression in primary cultured rat hepatocytes. Drug Metab Dispos 2003; 31: 1260-1268.
84. Acosta-Martínez M. PI3K: an attractive candidate for the central integration of metabolism and reproduction. Front Endocrinol (Lausanne) 2011; 2:110.
85. Ki SH, Kim SG. Phase II enzyme induction by alpha-lipoic acid through phosphatidylinositol 3-kinase-dependent C/EBPs activation. Xenobiotica 2008; 38:587-604.
86. Sobinoff AP, Mahony M, Nixon B, Roman SD, McLaughlin EA. Understanding the villain: DMBA-induced preantral ovotoxicity involves selective follicular destruction and primordial follicle activation through PI3K/Akt and mTOR signaling. Toxicol Sci 2011; 123:563-575.
87. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A 1995; 92:4728-4732.
88. Yang Z, Norwood KA, Smith JE, Kerl JG, Wood JR. Genes involved in the immediate early response and epithelial-mesenchymal transition are regulated by adipocytokines in the female reproductive tract. Mol Reprod Dev 2012; 79:128-137.
89. Benedict JC, Miller KP, Lin TM, Greenfeld C, Babus JK, Peterson RE, Flaws JA. Aryl hydrocarbon receptor regulates growth, but not atresia, of mouse preantral and antral follicles. Biol Reprod 2003; 68:1511-1517.
90. Kezele PR, Nilsson EE, Skinner MK. Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 2002; 192:37-43.
91. Wang N, Luo LL, Xu JJ, Xu MY, Zhang XM, Zhou XL, Liu WJ, Fu YC. Obesity accelerates ovarian follicle development and follicle loss in rats. Metabolism 2014; 63:94-103.
92. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010; 17: 718-726.
93. Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR. Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008; 15:857-861.
94. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88:1516-1522.
95. Britt KL, Drummond AE, Dyson M, Wreford NG, Jones ME, Simpson ER, Findlay JK. The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol 2001; 79:181-185.
96. Shimada T, Oda Y, Gillam EM, Guengerich FP, Inoue K. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos 2001; 29:1176-1182.
97. Shimada T, Sugie A, Shindo M, Nakajima T, Azuma E, Hashimoto M, Inoue K. Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol Appl Pharmacol 2003; 187:1-10.
98. Cannady EA, Dyer CA, Christian PJ, Sipes IG, Hoyer PB. Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol Sci 2002; 68:24-31.
99. Rajapaksa KS, Cannady EA, Sipes IG, Hoyer PB. Involvement of CYP 2E1 enzyme in ovotoxicity caused by 4-vinylcyclohexene and its metabolites. Toxicol Appl Pharmacol 2007; 221:215-221.
100. Hakkak R, Holley A, MacLeod S, Simpson P, Fuchs G, Jo C, Kieber-Emmons T, Korourian S. Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female Zucker rats. Breast Cancer Research 2005; 7:R627-R633.
101. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007; 113:234-258.
102. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR. Increased skin tumorigenesis in mice lacking pi class glutathione Stransferases. Proc Natl Acad Sci U S A 1998; 95:5275-5280.
103. Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, Wolf CR. Pi-class glutathione S-transferase: regulation and function. Chem Biol Interact 1998; 111-112:69-82.
104. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88.
105. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30:445-600.
106. Listowsky I, Abramovitz M, Homma H, Niitsu Y. Intracellular binding and transport of hormones and xenobiotics by glutathione-S-transferases. Drug Metab Rev 1988; 19:305-318.
107. Laborde E. Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 2010; 17: 1373-1380.
108. Townsend DM, Tew KD. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 2003; 22:7369-7375.
109. Townsend D, Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics 2003; 3:157-172.
110. Tew KD, Townsend DM. Regulatory functions of glutathione Stransferase P1-1 unrelated to detoxification. Drug Metab Rev 2011; 43: 179-193.
111. Tew KD. Drug resistance in cancer. Editorial. Biochem Pharmacol 2012; 83:985-986.
112. Green JA, Robertson LJ, Clark AH. Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 1993; 68:235-239.
113. Zhang J, Liu H, Yan H, Huang G, Wang B. Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: a metaanalysis. Gene 2013; 518:405-411.
114. Tew KD, Manevich Y, Grek C, Xiong Y, Uys J, Townsend DM. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 2011; 51:299-313.
115. Morrow CS, Diah S, Smitherman PK, Schneider E, Townsend AJ. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis 1998; 19:109-115.